Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and ...

Intermountain Health is the first in the nation to use a new tool using a 3D computer model for rectal cancer surgery. The new technology, called Iris, guides surgeons during robotic rectal cancer ...

Kelly Spill didn’t cry when she was diagnosed with stage III rectal cancer at age 28. She held her emotions together when her surgeon told her that she might not be able to carry another baby — ...

Molecular recurrence signals preceded symptoms or imaging in all recurrences observed, indicating ctDNA may enable earlier intervention than conventional surveillance paradigms. Post-neoadjuvant ctDNA ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients who received only an immune-based treatment to help their own immune ...

Stage 3 colorectal cancer patients with MRD benefit from Celebrex addition to chemotherapy, showing a 40% risk reduction in death for Signatera-positive patients. Celebrex improved disease-free and ...

Five-Year Overall Survival Analysis of the JIPANG Study: Pemetrexed or Vinorelbine Plus Cisplatin for Resected Stage II-IIIA Nonsquamous Non–Small-Cell Lung Cancer The majority of older patients ...

The Philippine Health Insurance Corporation (PhilHealth) is reminding members that they may receive up to PHP400,000 in financial coverage for the treatment of advanced colorectal cancer under its Z ...